Is the Options Market Predicting a Spike in Globe Life Stock? — Neutral

GL   Zacks Investment Research — December 17, 2025

Investors need to pay close attention to Globe Life stock based on the movements in the options market lately.

image for news Is the Options Market Predicting a Spike in Globe Life Stock?

A Quiet Day? WBD, Fed Chair Interviews, Earnings Reports — Neutral

WBD   Zacks Investment Research — December 17, 2025

Between WBD's letter to shareholders, interviews for a new Fed Chair and off-season earnings this morning and afternoon, we've got plenty of grist for the trading mill today.

image for news A Quiet Day? WBD, Fed Chair Interviews, Earnings Reports

2 Quantum Stocks I'm Watching Closely for 2026 — Neutral

GOOG  IONQ   24/7 Wall Street — December 17, 2025

As the new year approaches, it's not hard to imagine that many risk takers are wondering what the next move will be in the fast-paced field of quantum computing.

image for news 2 Quantum Stocks I'm Watching Closely for 2026

Gold up, silver soars to record high on safe-haven bids — Positive

AAAU  BAR  DBP  DGL  GLD  GLDM  IAU  OUNZ  SGOL  SIL  SILJ  SIVR  SLV  SLVP  UGL   Kitco — December 17, 2025

Jim Wyckoff has spent over 25 years involved with the stock, financial and commodity markets. He was a financial journalist with the FWN newswire service for many years, including stints as a reporter on the rough-and-tumble commodity futures trading floors in Chicago and New York.

image for news Gold up, silver soars to record high on safe-haven bids

Can The Trade Desk's OpenPath Transform the Digital Ad Supply Chain? — Positive

TTD   Zacks Investment Research — December 17, 2025

TTD is pushing OpenPath as a structural upgrade to digital ads, creating cleaner, direct links to premium publishers as adoption and usage surge.

image for news Can The Trade Desk's OpenPath Transform the Digital Ad Supply Chain?

GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment — Positive

GSK   Zacks Investment Research — December 17, 2025

GSK secures FDA approval for Exdensur, the first twice-yearly biologic for treating severe asthma with an eosinophilic phenotype.

image for news GSK's Exdensur Gets FDA Nod for Severe Asthma Treatment

FEIM Stock Up 29% Despite Q2 Earnings Dip Y/Y on Contract Delays — Negative

FEIM   Zacks Investment Research — December 17, 2025

Frequency Electronics' fiscal Q2 earnings fall year over year amid earlier contract delays and rising cost pressures despite strong revenue and backlog growth.

image for news FEIM Stock Up 29% Despite Q2 Earnings Dip Y/Y on Contract Delays

Both monthly maintenance doses (100 mg and 300 mg) improved opioid abstinence and were well-tolerated with no new safety signals identified. Post-hoc analyses indicated the 300-mg monthly maintenance dose performed significantly better than the 100-mg monthly dose in participants reporting high-frequency fentanyl use.

image for news New Study Shows Extended-Release Buprenorphine Safely Delivers Rapid, Clinically Meaningful Reductions in Opioid Use and Supports Abstinence in High-Risk Populations

NEWTON, Mass.--(BUSINESS WIRE)--Omdia by Informa TechTarget named Analyst Firm of the year, honored with multiple prestigious awards from industry organizations.

image for news Omdia by Informa TechTarget Named Analyst Firm of the Year and Earns Multiple Industry Accolades

'This is a huge opportunity' to fuel reactors sooner and faster, says Oklo's CEO — Positive

OKLO   CNBC Television — December 17, 2025

Oklo CEO Jacob DeWitte joins ‘Squawk on the Street' following to discuss turning plutonium stockpiles into energy, Oklo's reactor concept and more.

image for news 'This is a huge opportunity' to fuel reactors sooner and faster, says Oklo's CEO

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of Two Harbors Investment Corp. (NYSE: TWO) to UWM Holdings Corporation for 2.3328 shares of UWM Class A Common Stock for each share of Two Harbors common stock is fair to Two Harbors shareholders. Halper Sadeh encourages Two Harbors shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or sadeh@halpersade.

image for news TWO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Two Harbors Investment Corp. is Fair to Shareholders

Janus Henderson Concentrated Growth Managed Account Q3 2025 Portfolio Review — Negative

JHG   Seeking Alpha — December 17, 2025

Apple's stock faced headwinds earlier in 2025 because of sluggish iPhone sales, weaker consumer spending in China, and uncertainty about tariffs. Marvell has been a beneficiary of increasing demand for data infrastructure – primarily custom silicon – through its relationship with Amazon. Oracle reported strong second-quarter results and exceptional forward guidance, especially for its Oracle Cloud Infrastructure business.

image for news Janus Henderson Concentrated Growth Managed Account Q3 2025 Portfolio Review

Together with customers, employees and local partners, Duke Energy is making a difference – providing critical energy assistance so families can stay safe and connected during challenging times. CHARLOTTE, N.C.

image for news Duke Energy and partners help customers in need stay safe, warm and connected

Micron Technology Inc.'s (NASDAQ: MU) stock is sliding into first quarter earnings — not because the AI memory story is cracking, but because expectations have finally caught up. After a 166% year-to-date rally, MU is coming off its highs, down nearly 9% over the past five days, setting up what may be the most consequential quarter of the cycle.

image for news Micron's Monster 2025 Run Meets Its Biggest Quarter Yet — And The Stock Is Slipping

3 Stocks to Consider From the Prospering Consulting Services Industry — Positive

CBZ  EXPO  FCN   Zacks Investment Research — December 17, 2025

The Zacks Consulting Services industry is poised to prosper, with service activities remaining healthy. FCN, EXPO and CBZ are three stocks that are well-placed to ride the demand strength.

image for news 3 Stocks to Consider From the Prospering Consulting Services Industry

Can EMCOR Maintain Its 9.1% Margin Streak as Data Centers Explode? — Positive

EME   Zacks Investment Research — December 17, 2025

EME's improving margin streak is being tested as data center demand reshapes backlog, execution discipline and operating leverage.

image for news Can EMCOR Maintain Its 9.1% Margin Streak as Data Centers Explode?

Bill Gates and Ken Fisher are quietly sitting on massive gains from one of 2025's most overlooked winners. Caterpillar Inc (NYSE: CAT), now the top-performing stock in the Dow, is up more than 62% year-to-date.

image for news Bill Gates, Ken Fisher Rake In $1.7 Billion From Dow Stock That Trounced Nvidia

WILMINGTON, Del.--(BUSINESS WIRE)---- $INCY--Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma.

image for news Incyte Announces European Commission Approval of Minjuvi® (tafasitamab) for the Treatment of Relapsed or Refractory Follicular Lymphoma

NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

image for news NeuroOne Medical Technologies Corporation (NMTC) Q4 2025 Earnings Call Transcript

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating whether the sale of United Security Bancshares (NASDAQ: UBFO) to Community West Bancshares for 0.4520 shares of Community West common stock for each share of United Security common stock is fair to United Security shareholders. Halper Sadeh encourages United Security shareholders to click here to learn more about their legal rights and options or contact Daniel Sadeh or Zachary Halper at (212) 763-0060 or.

image for news UBFO Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of United Security Bancshares is Fair to Shareholders